Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kirk D. Robarge
Observed names:
K. D. ROBARGE,
K. D. Robarge,
K. Robarge,
K.D. Robarge,
Kirk D Robarge,
Kirk Robarge,
Robarge, Kirk
show all 7
Institution:
Genentech
Observed institutions:
Genentech,
University of California, Irvine,
Purdue University West Lafayette,
Array BioPharma (United States)
OpenAlex ID:
A5089907620
GDC-0449—A potent inhibitor of the hedgehog pathway
2009
·
Kirk D. Robarge
, Shirley A. Brunton
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
422
Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
2010
·
Gerrit J. P. Dijkgraaf
, Bruno Alicke
, et al.
·
Cancer Research
·
392
PDF
Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
2016
·
Aaron Boudreau
, Hans E Purkey
, et al.
·
Nature Chemical Biology
·
301
Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
2016
·
James F. Blake
, Michael Burkard
, et al.
·
Journal of Medicinal Chemistry
·
169
PDF
From Peptide to Non-Peptide. 2. The de Novo Design of Potent, Non-peptidal Inhibitors of Platelet Aggregation Based on a Benzodiazepinedione Scaffold
1994
·
Robert S. McDowell
, Brent K. Blackburn
, et al.
·
Journal of the American Chemical Society
·
108
Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists
2015
·
Benjamin P. Fauber
, Alberto Gobbi
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
75
Discovery and preclinical development of vismodegib
2014
·
Stephen E Gould
, Jennifer A Low
, et al.
·
Expert Opinion on Drug Discovery
·
74
Accelerated inverse electron demand Diels-Alder reactions of 1-oxa-1,3-butadienes: [4 + 2] cycloaddition reactions of .beta.,.gamma.-unsaturated .alpha.-keto esters
1988
·
Dale L. Boger
, Kirk D. Robarge
·
The Journal of Organic Chemistry
·
72
From Peptide to Non-Peptide. 3. Atropisomeric GPIIbIIIa Antagonists Containing the 3,4-Dihydro-1H-1,4-benzodiazepine-2,5-dione Nucleus
1997
·
Brent K. Blackburn
, Arthur Lee
, et al.
·
Journal of Medicinal Chemistry
·
69
Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice
2016
·
Hans E. Purkey
, Kirk Robarge
, et al.
·
ACS Medicinal Chemistry Letters
·
62
Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor
2009
·
H. Wong
, J.Z. Chen
, et al.
·
Xenobiotica
·
60
Divergent de novo synthesis of carbohydrates based on an accelerated inverse electron demand Diels-Alder reaction of 1-oxa-1,3-butadienes
1988
·
Dale L. Boger
, Kirk D. Robarge
·
The Journal of Organic Chemistry
·
56
Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase
2014
·
Peter S. Dragovich
, Benjamin P. Fauber
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
50
Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479
2014
·
Kirk D. Robarge
, Wendy Lee
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
46
PDF
Corrigendum to “GDC-0449—A potent inhibitor of the hedgehog pathway” [Bioorg. Med. Chem. Lett. 19 (2009) 5576]
2009
·
Kirk D. Robarge
, Shirley A. Brunton
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
45
Stereoselectivity in the electrophile-mediated cyclization of 2,3,5-tri-O-benzyl-1,2-dideoxy-d-arabino-hex-1-enitol. A stereocontrolled synthesis of 1-amino-2,5-anhydro-3,4,6-tri-O-benzyl-1-deoxy-d-glucitol
1987
·
Fillmore Freeman
, Kirk D. Robarge
·
Carbohydrate Research
·
44
A Selective, Slow Binding Inhibitor of Factor VIIa Binds to a Nonstandard Active Site Conformation and Attenuates Thrombus Formation in Vivo
2005
·
Alan G. Olivero
, Charles Eigenbrot
, et al.
·
Journal of Biological Chemistry
·
42
Mono-N-alkylation of anthranilamides via quinazolinones. An efficient synthesis of G5598, a benzodiazepine dione gpIIbIIIa antagonist
1994
·
Robert R Webb
, Peter L Barker
, et al.
·
Tetrahedron Letters
·
42
Preclinical Disposition of GDC-0973 and Prospective and Retrospective Analysis of Human Dose and Efficacy Predictions
2012
·
Edna F. Choo
, Marcia Belvin
, et al.
·
Drug Metabolism and Disposition
·
34
A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors
2013
·
Wendy Lee
, Daniel F. Ortwine
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
31
Stereoselectivity in electrophile-mediated intramolecular cyclizations of hept-2-enitols
1989
·
Fillmore Freeman
, K. D. Robarge
·
The Journal of Organic Chemistry
·
31
Electrophile-mediated cyclizations in carbohydrate chemistry: synthesis of highly functionalized ribofuranose and ribopyranose compounds
1985
·
Fillmore Freeman
, K.D. Robarge
·
Tetrahedron Letters
·
31
Pharmacokinetics, Pharmacodynamics and Tolerability of a Potent, Non-peptidic, GP IIb/IIIa Receptor Antagonist following Multiple Oral Administrations of a Prodrug Form
1998
·
Nishit Modi
, Sherron Bullens
, et al.
·
Thrombosis and Haemostasis
·
29
Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenase
2014
·
Benjamin P. Fauber
, Peter S. Dragovich
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
26
PDF
Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase
2014
·
Sharada Labadie
, Peter S. Dragovich
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
24
PDF
Show more works
View as search
Works count:
55
Citation count:
2,495
H-index:
24
I10-index:
33
Year
Topic
Type